Fresenius Medical Care AG & Co. KGaA
How Does Cantel Medical Compare to Its Peers?
Cantel Medical outperformed its peers based on the net profit margin, current ratio, PE ratio, and PBV ratio. It outperformed its ETFs based on the PBV ratio.
Cantel Medical’s Revenue and Income Rose in 4Q15
Cantel Medical reported net revenue of $151.255 million in 4Q15—a rise of 6.88% compared to the net revenue of $141.508 million in 3Q15.
Expert Q&A: What to Know Before Investing in Generic Pharma? (Part 1)
Market Realist analysts recently conducted a Q&A with experts from VanEck on the generic pharmaceutical industry, a space that has attracted investor interest due to upside potential from brand name drugs coming off patent, cost saving pressure in the healthcare industry, and increased worldwide demand for prescription drugs (for more on these topics, please see […]
Shire: Why Analysts Expect Revenue Growth in Q3 2018
Analysts are expecting Shire (SHPG) to report a 3.3% growth in revenue when it reports its third-quarter earnings on November 1.
DaVita’s Valuation on September 17
DaVita currently trades at a forward PE multiple of 15.2x compared to the industry average of 15.1x as of September 17.
How the Healthcare Sector’s Dividend Yield Stacks Up
The healthcare industry has an average dividend yield of 1.9%.
The Hospital Business Remains 1of HAE’s Key Growth Drivers
In fiscal 3Q18, Haemonetics (HAE) reported revenue of close to $46.7 million in its hospital business, a YoY (year-over-year) rise of ~9.1%.
Fresenius Medical Care Is a Global Leader in the Dialysis Segment
In addition to selling dialysis products, Fresenius Medical Care also offers dialysis treatment and associated laboratory services to patients through its network of 3,690 clinics.
EMEA and APAC: Fresenius Medical Care’s Dialysis Products Business
In 1H17, Fresenius Medical Care (FMS) earned ~1.6 billion euros from the sale of dialysis products, which equals year-over-year growth of 8% on a reported basis.
North America: Fresenius Medical Care’s Major Target Market in 2017
In 2Q17, Fresenius Medical Care (FMS) reported revenues close to 3.3 billion euros, which represents year-over-year growth of ~11%.
Fresenius Medical Care’s Net Profit Margins Could Fall Slightly
For fiscal 2017, Wall Street analysts have projected Fresenius Medical Care’s net profit margins to be close to 6.2%, which is a YoY decline of ~70 basis points.
How Analysts View Fresenius Medical Care and Its Peers in August 2017
In 1H17, Fresenius Medical Care (FMS) reported revenues close to 9.0 billion euros, which represents 14% YoY growth. At the end of 2Q17, the company operated 3,690 dialysis clinics around the world.
Consumer Staples Delivered Top-Notch Performance for VGEAX
The Virtus Greater European Opportunities Fund – Class A (VGEAX) rose 1.3% in 1Q16. It was the only fund to post gains for the period, making it the best of the 12 funds in this review.
What’s the Harding Loevner International Equity Portfolio’s Strategy?
The Harding Loevner International Equity Portfolio invests in developed markets except the US and in established companies from emerging and frontier markets.
European Central Bank’s Monetary Policy: Why the Disappointment?
When monetary policy is eased, domestic currency can be expected to weaken.
Medtronic purchases Cardiocom: Bad for medical device industry?
Medtronic has always been considered a bellwether for the medical device industry because of its pure focus on the device market. Yet that changed in mid-August, as Medtronic announced its acquisition of Cardiocom.